P53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer

  • Benjamin L. Maughan
  • , Liana B. Guedes
  • , Kenneth Boucher
  • , Gaurav Rajoria
  • , Zach Liu
  • , Szczepan Klimek
  • , Roberto Zoino
  • , Emmanuel S. Antonarakis
  • , Tamara L. Lotan

Research output: Contribution to journal › Article › peer-review

58   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'P53 status in the primary tumor predicts efficacy of subsequent abiraterone and enzalutamide in castration-resistant prostate cancer'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience